Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-26

Clinical Trial Update: Mirror Neuron Network Dysfunction as an Early Biomarker of Neurodevelopmental Disorder

View source ↗

Summary

An NICHD-sponsored clinical trial evaluating mirror neuron network dysfunction as an early biomarker for a neurodevelopmental disorder is currently recruiting p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Developmental Delay | Status: RECRUITING